Back working full time in my Day JOB :(((. They need me :(( Sporadig trading for now
Followers | 141 |
Posts | 7,182 |
Boards Moderated | 1 |
Alias Born | 07/06/2006 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
KSPN, is moving based on good fiscal report.
PUGE> bids stacking.. ask getting wiped.. will watch.
PUGE> bids stacking.. ask getting wiped.. will watch.
why is this moving , near closing hour..
DCAC
PBYA @0.0031.. looks like it is getting loaded.. will add to watch ,, will buy below 0.0029..
This play will take months to build so plan it perfectly..
HAPPY NEW YEAR..
PBYA @0.0031.. looks like it is getting loaded.. will add to watch ,, will buy below 0.0029..
This play will take months to build so plan it perfectly..
HAPPY NEW YEAR..
Once this news is digested, and they do their DD .. XALL will go back to 0.03..
take care guys.
XALL NEWS... Cryptocurrency Trading Solution
WASHINGTON, DC , Nov. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Xalles Holdings Inc. (OTC: XALL), a fintech holding company providing innovative technology and financial services solutions to capitalize on the growing cryptocurrency and digital asset market, today announced a joint venture between Xalles Capital Inc. and Aktary Enterprises LLC (DBA AktaryTech) to establish GioBot Inc.
Headquartered in Austin TX , GioBot’s Software-as-a-Service solution will allow crypto traders to easily implement their own unique trading strategies and automate execution of cryptocurrency trades. By enhancing their investment processes, crypto traders can take their trading to the next level by systematically running single or even multiple algorithmic trading strategies across a variety of centralized and decentralized venues. The platform will also offer in-depth reporting and analytics on traders' positions and market conditions. With built-in scripting support, traders will be able to infinitely modify strategies to account for the dynamic nature of market conditions.
GioBot will be led by Paul Giordano . Mr. Giordano brings over 30 years of experience in the global financial services industry to GioBot. Prior to helping launch GioBot he founded and led Tamalpias Asset Management, a $350mm assets under management hedge fund and was CIO of Creedon, Keller and Partners , a $2.1 billion alternative asset manager. Mr. Giordano also held senior positions at Merrill Lynch and Societe Generale/FIMAT and Redback Networks.
"Traders in the volatile and dynamic crypto market will significantly benefit by having access to the same type of tools and capabilities that traditional asset class institutional traders have been using for years," said Paul Giordano , President. "Leveraging GioBot will give our customers the edge they need to maximize their capital return potential in this rapidly evolving environment."
Xalles Capital Inc. , a wholly owned subsidiary of Xalles Holdings , previously acquired Vigor Crypto Holdings to create trading strategies and manage internal crypto assets. This new GioBot joint venture with AktaryTech builds on what we have learned in the past couple of years. While Vigor Crypto will continue to manage the internal Xalles crypto assets, GioBot will create a platform that can be used by external traders. “Vigor has a proven successful business model and continues to generate profits for the company. Through GioBot, we will offer crypto traders, as well as institutional clients, access to expanded trading solutions to capture meaningful profitable revenue streams,” stated Xalles Holdings Chief Revenue Officer Everett Doolittle , who will also be named as one of the GioBot directors.
About Xalles Holdings Inc.
Xalles Holdings Inc. is a holding company that focuses on direct investments in disruptive fintech companies. The company actively seeks acquisition targets in which it can invest and accelerate growth, targeting companies with solid management teams and business models, large total attainable markets (TAM), and lucrative exit opportunities. The company places emphasis on leveraging blockchain technologies to provide industry-leading financial reconciliation and auditing solutions, which, over time, will allow for the capture of recurring revenue streams.
About Aktary Enterprises LLC
Aktary Enterprises LLC is a privately-owned, diversified technology and cryptofinance company, founded in 2008 and headquartered in Austin , Texas. Through its AktaryTech brand, established in 2014, it leverages its unique insights in web, mobile, blockchain, and other technologies to provide its clients with best-in-class professional services in product development, staff augmentation, and consulting. AktaryTech’s R&D division also develops and markets its own ground-breaking products and services.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov and in OTC Markets at www.otcmarkets.com
Investor Relations Contacts:
info@xalles.com
info@aktarytech.com
202.595.1299 Xalles Office
310.254.9990 AktaryTech Office
.. nice.. finally
yea, less than 50m volume in OTC, is dumping.. great..
so no dumping will be less than 5m volume, or less than one million volume..
could you tell me.. thank you
XALL NEWS...
WASHINGTON, DC , Nov. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Xalles Holdings Inc. (OTC: XALL), a fintech holding company providing innovative technology and financial services solutions to capitalize on the growing cryptocurrency and digital asset market, today announced a joint venture between Xalles Capital Inc. and Aktary Enterprises LLC (DBA AktaryTech) to establish GioBot Inc.
Headquartered in Austin TX , GioBot’s Software-as-a-Service solution will allow crypto traders to easily implement their own unique trading strategies and automate execution of cryptocurrency trades. By enhancing their investment processes, crypto traders can take their trading to the next level by systematically running single or even multiple algorithmic trading strategies across a variety of centralized and decentralized venues. The platform will also offer in-depth reporting and analytics on traders' positions and market conditions. With built-in scripting support, traders will be able to infinitely modify strategies to account for the dynamic nature of market conditions.
GioBot will be led by Paul Giordano . Mr. Giordano brings over 30 years of experience in the global financial services industry to GioBot. Prior to helping launch GioBot he founded and led Tamalpias Asset Management, a $350mm assets under management hedge fund and was CIO of Creedon, Keller and Partners , a $2.1 billion alternative asset manager. Mr. Giordano also held senior positions at Merrill Lynch and Societe Generale/FIMAT and Redback Networks.
"Traders in the volatile and dynamic crypto market will significantly benefit by having access to the same type of tools and capabilities that traditional asset class institutional traders have been using for years," said Paul Giordano , President. "Leveraging GioBot will give our customers the edge they need to maximize their capital return potential in this rapidly evolving environment."
Xalles Capital Inc. , a wholly owned subsidiary of Xalles Holdings , previously acquired Vigor Crypto Holdings to create trading strategies and manage internal crypto assets. This new GioBot joint venture with AktaryTech builds on what we have learned in the past couple of years. While Vigor Crypto will continue to manage the internal Xalles crypto assets, GioBot will create a platform that can be used by external traders. “Vigor has a proven successful business model and continues to generate profits for the company. Through GioBot, we will offer crypto traders, as well as institutional clients, access to expanded trading solutions to capture meaningful profitable revenue streams,” stated Xalles Holdings Chief Revenue Officer Everett Doolittle , who will also be named as one of the GioBot directors.
About Xalles Holdings Inc.
Xalles Holdings Inc. is a holding company that focuses on direct investments in disruptive fintech companies. The company actively seeks acquisition targets in which it can invest and accelerate growth, targeting companies with solid management teams and business models, large total attainable markets (TAM), and lucrative exit opportunities. The company places emphasis on leveraging blockchain technologies to provide industry-leading financial reconciliation and auditing solutions, which, over time, will allow for the capture of recurring revenue streams.
About Aktary Enterprises LLC
Aktary Enterprises LLC is a privately-owned, diversified technology and cryptofinance company, founded in 2008 and headquartered in Austin , Texas. Through its AktaryTech brand, established in 2014, it leverages its unique insights in web, mobile, blockchain, and other technologies to provide its clients with best-in-class professional services in product development, staff augmentation, and consulting. AktaryTech’s R&D division also develops and markets its own ground-breaking products and services.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov and in OTC Markets at www.otcmarkets.com
Investor Relations Contacts:
info@xalles.com
info@aktarytech.com
202.595.1299 Xalles Office
310.254.9990 AktaryTech Office
.. nice.. finally
ARSN... This stock , chart looking good for 0.0022 and above reversal.. but we needs more days of accumulation on 0.0014 to 0.0018 ranges
Added to watch
AEI, is the one I purchased yesterday on the dip to 3.98.. It had recent offering, but small, and still will have small float.
I am gonna long swing this ,, looking for $7 in few weeks.
3 Short Squeeze Candidates In The Real Estate Sector
by Wayne Duggan
May 12, 2021 6:55 pm
Low float stocks can be some of the most volatile stocks in the market. If you mix in a short squeeze, the potential short-term gains in a low float stock can be extreme.
A stock's float is the number of shares that trade freely on the public market. Because insiders and institutional investors don’t typically trade their shares on a daily basis, those shares don’t typically contribute to a stock's near-term liquidity.
Float is the number of shares that remain after accounting for insider and institutional ownership.
New Traders Swear By Benzinga Options
?????
"9 out of 10 trades are winners!" - Cameron W. Houston, TX
We sift through this volatile market for consistent trades so you don't have to. Get Benzinga Options: Starter Edition to follow Benzinga's high-conviction options trades.
Click here to get my trades!
Why Is It Important? When a stock gains positive momentum in the market, momentum buyers can rush in all at once. If a stock has a high short interest, short covering can quickly ramp up demand for shares, triggering a short squeeze. Since low float stocks have relatively few shares trading freely, a major imbalance in supply and demand can serve as rocket fuel for the share price.
Buying a low float stock with high short interest isn’t a guarantee of a short squeeze. There still typically needs to be some form of catalyst to get the stock moving in the first place. However, traders can keep an eye on these stocks for any signs of life to try to catch most of a potential big move.
Short Squeeze Candidates: Here are three real estate sector stocks that have all the ingredients for a short squeeze.
Related Link: 3 Short Squeeze Candidates In The Health Care Sector
Alset Ehome International Inc (NASDAQ:AEI)
Alset EHome engages in land development, technology and biohealth. The stock is also the perfect short squeeze candidate within the sector.
Alset’s 770,000-share float is minuscule, creating plenty of opportunity for extreme volatility if trading volume rises. Alset also has a relatively high 18.5% of its float held short.
The stock has previously demonstrated its potential for extreme volatility. In less than two weeks back in February, Alset’s stock price rocketed from around $6 to as high as $29.49. Finally, short squeeze traders have frequently targeted stocks trading under $5 per share this year, and Alset’s shares currently trade at just $4.11.
Washington Prime Group Inc (NYSE:WPG)
Washington Prime owns, manages and develops retail properties.
Washington Prime has reported declining revenues in each of the past five years, but as many meme stock traders have realized in 2021, short squeezes are technical market phenomena and don’t necessarily have anything to do with the company’s underlying business fundamentals or the stock’s long-term outlook.
Washington Prime has a relatively small float of 20.5 million shares, the highest short percent of float of the three stocks mentioned at 34.7%, and a stock price of just $1.97, making it a prime short squeeze target.
Seritage Growth Properties (NYSE:SRG)
Seritage Growth Properties is another retail property real estate investment trust that focuses on malls, shopping centers and freestanding locations.
Seritage has a relatively small float of 34.3 million shares and a 16.2% short percent of float. The stock also has a history of extreme volatility. From mid-May to early June 2020, Seritage’s stock price surged from $6.03 to as high as $24.06.
May 11, 2021 11:50 AM ET (BZ Newswire) -- Cannabis
A Complete list of NYSE and NASDAQ - Listed Cannabis Companies:
As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.
Given the federal uncertainty that still surrounds cannabis in America and in most of the world, few cannabis companies choose the path of a public listing in order to raise funds and even fewer among them are pure-play marijuana stocks.
* Versión en Español: Una Lista Completa de Empresas de Cannabis Con Acciones en las Bolsas NYSE y NASDAQ.
Listing Vs. Other Funding Sources
Cannabis companies are typically able to raise money from venture capital firms, or they can list their stock.
Listing a stock allows enables fundraising from a larger pool of investors. At the same time, a publicly-traded stock can be volatile, and even more so in an emerging sector like cannabis.
Even though listing on a major exchange such as the NYSE and NASDAQ requires a company to comply with strict transparency and accountability rules, it also sends investors a sign that the company is serious about its business.
Benzinga has compiled a list of NYSE- and NASDAQ-listed cannabis companies, as well as a short description of the company's involvement in the sector. In the first part of the list, we focused on pure-play stocks: companies for which cannabis is their core business.
Akerna Corp (NASDAQ:KERN)
Akerna was launched on June 17, 2019, following the merger of cannabis-focused blank check company MTech Acquisition Corp and MJ Freeway, a provider of seed-to-sale regulatory compliance technology and Enterprise Resource Planning platform.
Akerna is the first cannabis compliance technology company to be traded on NASDAQ and is the first NASDAQ-listed cannabis company led by a woman. The company allows cannabis businesses to connect data points in their supply chain making it more transparent and accountable.
Amyris (NASDAQ:AMRS)
Amyris is a science and technology company that creates and manufactures sustainable ingredients for various markets, such as Clean Health & Beauty, and Flavors & Fragrances. Its connection to the cannabis industry is through the research and production of biosynthetic cannabinoids, including CBG.
(*Note – the company has inked a deal with the biotech startup Lavvan to research and develop synthetic cannabinoids in 2019. Last September, Lavvan sued the company for “wrongful use of Lavvan intellectual property in connection with their development, testing, and production of biosynthetic cannabinoids, including CBG.”)
Aphria Inc (NYSE:APHA)
Canadian medical marijuana producer Aphria became the first pure-play cannabis company to trade on the NYSE. The stock debuted on the major exchange on Nov. 2, 2018.
Prior to that, Aphria's stock had been listed on the over-the-counter market in the U.S. and on the Toronto Stock Exchange. Listing on the NYSE was a major step for Aphria, opening the company to a larger pool of investors.
Applied DNA Sciences Inc. (NASDAQ:APDN)
Applied DNA Sciences is a biotechnology company that provides molecular technologies that promote supply chain security, anti-counterfeiting and anti-theft technology. Last year, the company entered a $5 million agreement with a Canadian cannabis consultancy TheraCann International Benchmark to use the company’s “molecular tagging” technology in the cannabis industry. Last year, at an international cannabis conference in Panama, Applied DNA presented its new marijuana tracking technology.
Arena Pharmaceuticals (NASDAQ:ARNA)
Arena Pharmaceuticals is a biotech company located in San Diego, which has one segment of its drug pipeline dedicated to cannabinoid-type therapeutics. Other parts of its drug pipeline are focused on non-cannabinoid drugs. The core of its cannabis biotech operations is the research and development of its investigational drug candidate called Olorinab (APD371). This is an oral full agonist of the cannabinoid receptor 2 that is being researched for the treatment of various symptoms, mainly concentrated on visceral pain connected with gastrointestinal illnesses.
Aurora Cannabis Inc (NYSE:ACB)
Canadian marijuana producer Aurora Cannabis is considered one of the best stocks for full exposure to the cannabis industry. Aurora is one of the largest cannabis companies in the world. It operates eight licensed production facilities, with five sales licenses and operations in 18 countries. The company has a funded production capacity of over 500,000 kilograms. Aurora recently acquired MedReleaf in a $2.5-billion merger, the industry’s largest.
Canopy Growth Corp (NYSE:CGC)
Canopy Growth is the largest marijuana company in the world by market capitalization. It’s also one of the largest in terms of funded production capacity, with a figure of over 500,000 kg. The company is moving fast in expanding its licensed grow space. It started the year with around 800,000 square feet, but recently it has said it reached a licensed platform of 4.3 million feet. Overall, Canopy has a production platform of 5.6 million feet, of which now 75 percent is licensed.
CannTrust Holdings Inc. (NYSE:CTST)
Delisted
On Feb. 25, CannTrust Holdings joined its peers on the New York Stock Exchange. CannTrust provides medical and recreational cannabis and cannabis products, operating a 450,000 square-foot facility in Pelham Ontario, which it plans to expand by another 390,000 square feet. CannTrust has a 60,000 square-foot packaging facility in Vaughan, Ontario. Outside of Canada, CannTrust works with Cannatrek Ltd in Australia and has a joint venture with STENOCARE in Denmark.
Cara Therapeutics (NASDAQ:CARA)
Clinical-stage biotechnology company, Cara Therapeutics, is involved in the research and design of various chemical entities to help treat pain and itching, with most of them created to address opioid receptors. In previous years the company was examining the potential of CR-701, a synthetic cannabinoid receptor agonist for treating neuropathic pain and its ability to minimize hyperalgesia and allodynia.
cbdMD Inc (NYSE:YCBD)
cbdMD offers a range of CBD products, such as tinctures, oil, gummies, topicals and pet products. Recently, the company has partnered with a number of athletes, such as retired UFC champion Quinton “Rampage” Jackson and professional golfer Bubba Watson.
On May 1, cbdMD changed its name from Level Brands and the ticker from LEVB to YCBD following a vote from shareholders. It's the only CBD-focused U.S. company traded on a major exchange.
Coffee Holding Co., Inc. (NASDAQ:JVA)
A family-run coffee business that has been operating since 1971, providing a plethora of coffee products across the U.S. and Canada, Coffee Holdings joined the cannabis industry this year. In October, the company signed binding agreements to attain a 49% ownership of The Jordre Well, LLC, a cannabidiol beverage company, run by founders of Cannuka, a popular CBD skin brand. Under the deal, The Jordre Well will help Coffee Holding in the creation and commercialization of CBD-infused line extensions for the current coffee brands in the company’s portfolio.
Compass Diversified Holdings (NYSE: CODI)
Compass Diversified Holdings is an investment and holdings company, concentrated on North American middle-market enterprises. It is run by Compass Group Management LLC, which has more than 20 years of experience in the field. Its interest in the cannabis industry is seen through its holdings of Manitoba Harvest and Hemp Oil Canada.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Corbus Pharmaceuticals is a Phase 3 clinical-stage pharmaceutical company concentrated on the development of new drugs to help with inflammatory and fibrotic illnesses by targeting the endocannabinoid system. Its principal drug candidate is called Lenabasum, and it is an oral, cannabinoid receptor type 2 agonist formed to help with chronic inflammation and fibrotic processes. The drug is also being tested for its potential in treating cystic fibrosis, systemic lupus erythematosus, and some other illnesses. Furthermore, the company is working on creating a pipeline of drug candidates that address the endocannabinoid system.
Cronos Group Inc (NASDAQ:CRON)
In February, Cronos Group became the first pure-play cannabis stock to list on a major U.S. exchange. Based in Canada, Cronos is a vertically integrated cannabis company whose core business is medical marijuana, but it is also involved in the recreational space following the full legalization of weed in Canada earlier this month. Similar to its peers, Cronos has been ramping up its production capacity and expects to grow over 47,000 kilograms in early 2019. In addition, Cronos owns Peace Naturals and Original BC, which are licensed to grow and sell medical marijuana in Ontario and British Columbia, respectively.
Eastside Distilling, Inc. (NASDAQ:EAST)
Eastside Distilling, Inc. is a producer of award-winning craft spirits in Portland, Oregon, operating for 12 years. It is known for its specially designed product portfolio containing Burnside Bourbon, West End American Whiskey, Portland Potato Vodka, and Hue-Hue Coffee Rum, among others. It is linked to the cannabis space through its ownership of Outlandish Beverages LLC, which manufactures and sells CBD-infused non-alcohol beverages.
FSD Pharma Inc. (NASDAQ:HUGE)
FSD Pharma is a biotech pharmaceutical research and development company that works on a pipeline of FDA-approved synthetic compounds directed at affecting the endocannabinoid system to help with various disorders of the central nervous system and autoimmune illnesses of the GI tract, skin, and the musculoskeletal system. Its subsidiary, FV Pharma, is a licensed producer under Canada’s Cannabis Act regulations with the license to grow cannabis in its facility in Cobourg, Ontario.
Greenlane Holdings, Inc. (NASDAQ:GNLN)
Greenlane went public on April 18. It's a Florida-based company that distributes over 140 brands of vaporizers and smoking accessories across the world through dispensaries, smoke shops, as well as through its e-commerce platforms.
The company doesn't provide any cannabis products, but it has major exposure to the industry and is betting big on its growth. Greenlane’s products are distributed across hundreds of licensed cannabis cultivators, processors and dispensaries.
GrowGeneration Corp. (NASDAQ:GRWG)
GroGeneration Corp. is a Denver-based hydroponics innovator and a distributor of agricultural products that also serves U.S. cannabis companies. It runs retail hydroponic and organic specialty gardening retail stores, providing plant nutrition, advanced lighting technology, and farming soils, among others. GrowGeneration recently announced the completion of its acquisition of California-based GrowBiz, one of the largest hydroponic garden centers in the U.S.6
GW Pharmaceuticals PLC (NASDAQ:GWPH)
Among pharmaceutical companies, UK-based GW Pharmaceutical is the closest to being a pure-play cannabis company.
GW is focused on developing cannabis-based drugs. Its Sativex drug, for the treatment of multiple sclerosis, was the first-ever natural cannabis plant derivative to be approved by regulators in any country, receiving UK approval in 2010. Earlier this year, Epidiolex, for the treatment of epilepsy, became the first cannabis-derived drug to bag FDA approval.
HEXO Corp (NYSE:HEXO)
Hexo is a Gatineau, Quebec-based adult-use cannabis company that focuses on innovative, smoke-free and traditional cannabis products. The company was previously known as Hydropothecary Corp, but changed its name to HEXO in August 2018 following the launch of the HEXO brand for the adult-use market (medical products retained the Hydropothecary brand).
In August 2018, HEXO and Molson Coors Brewing Co (NYSE:TAP)’s Canadian division agreed to form a joint venture (later revealed as Truss) to develop non-alcoholic, cannabis-infused beverages for the Canadian market. HEXO’s stock debuted on the NYSE American on Jan. 23.
India Globalization Capital, Inc. (NYSEAMERICAN: IGC)
India Globalization Capital is a Maryland-based company with two lines of operations – infrastructure, and cannabinoid-based products. Its cannabis-based products are designed to help with pain, seizures, post-traumatic stress disorder, and various other ailments. The company offers patent-pending products that provide micro-doses of cannabinoids mixed with other natural components.
Innovative Industrial Properties Inc (NYSE:IIPR)
Innovative Industrial Properties is the only publicly traded cannabis-focused Real Estate Investment Trust. The company manages a portfolio of real estate properties that it leases to medical cannabis companies in the U.S. Among its lessees are PharmaCann (New York and Massachusetts), The Pharm (Arizona), Holistic Industries (Maryland and Massachusetts), Green Peak (Michigan) and Vireo Health (Minnesota, New York, and Pennsylvania).
Intec Pharma Ltd. (NASDAQ:NTEC)
Intec Pharma is a biopharmaceutical company that works on creating a variety of therapeutics relying on its proprietary According Pill technology. Among, the company’s product pipeline candidates in clinical development are AP-cannabinoids. They are being examined for helping with various conditions such as cancer pain and opioid-sparing pain, by delivering one or both of the main cannabinoids naturally found in Cannabis sativa, CBD and THC.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products for various markets, such as agriculture and water treatment. The company’s three active ingredients are legalized for use on cannabis crops in California.
Neptune Wellness Solutions Inc. (NASDAQ:NEPT)
Neptune Wellness Solutions Inc. is a diversified wellness company. Through its 9354-7537 Quebec Inc., Neptune is licensed by Health Canada to process cannabis for the production of cannabis extracts and oils at its facility in Quebec. It is known for its proprietary recreational product line that includes High CBD Oil, High CBD Capsules, Classic Hashish, and Legacy Hashish.
NEWAGE (NASDAQ:NBEV)
NewAge is a Colorado-based omnichannel company that tries to motivate consumers to “live healthy.” It is the only one-stop shop of healthy beverages, with famous brands such as Nestea, Evian, Búcha Live Kombucha, Illy Coffee, and Volvic. Recently the company has announced that its Noni+CBD product has obtained sales approval by the Japanese Ministry of Health and the Japanese Narcotics Control Division. The company also offers a portfolio of hemp products, such as oils, body creams, and roll-on gels, which has reached Australia and New Zealand.
NIC Inc. (NASDAQ:EGOV)
The Olathe, Kansas-based provider of digital government services, NIC Inc. has reached the cannabis space through the acquisition of Complia, a Denver-based technology platform for regulating cannabis and hemp industries.
OrganiGram Holdings Inc (NASDAQ:OGI)
After announcing it had applied to list its stock on NASDAQ on April 26, it took slightly more than two weeks for the Canadian cannabis producer to get approved and another week for it to start trading on May 21.
OrganiGram produces indoor-grown medical and adult-use cannabis in Canada and has distribution across all 10 provinces. The company’s plants for recreational use have recently received organic certification from the Pro-Cert Organic Systems Ltd. In anticipation of the legalization of edibles in Canada later this year, OrganiGram has invested $15 million into an automated production line for cannabis-infused chocolate that has a capacity of 4.0 million kilograms per year, which will be delivered this fall.
Pyxus International Inc (NYSE:PYX)
Delisted
Until recently, Pyxus International was known as Alliance One International and was involved in tobacco growing and packaging. Earlier this year, the company rebranded into Pyxus as it embraced cannabis. In January, Pyxus’s subsidiary Canadian Cultivated Products acquired 75 percent of Canada’s Island Garden and 80 percent of Goldleaf Pharm. Later, Canadian Cultivated Products was rebranded into FIGR Cannabis.
At the beginning of October, Goldleaf received a cultivation license from Health Canada. In addition, Canada’s Island Garden has received a license to sell marijuana and signed an agreement with the province of Prince Edward Island for 1,000 kilograms of cannabis products. Moreover, Pyxus International’s Korent subsidiary is involved in the production of industrial hemp and hemp-derived CBD oil and liquid for e-cigarettes.
Sundial Growers Inc. (NASDAQ:SNDL)
Alberta-based cannabis company, Sundial Growers is known for cultivating a specific range of cannabis strains. It has established cannabis brands to Heal, Help and Play, with Heal symbolizing cannabis products consumed as prescribed medical therapies, Help products that support overall health and wellbeing via CBD, and Play that includes products for empowering social and spiritual occasions. The company runs two locations in Alberta, but it has announced plans to expand to British Columbia by building a new facility.
Therapix Biosciences Ltd (NASDAQ:TRPX)
Delisted
Israel-based Therapix Biosciences is involved in developing a pipeline of drugs based on the FDA-approved cannabinoid Dronabinol, such as THX-110 for the treatment of Tourette syndrome and obstructive sleep apnea, THX-130 for mild cognitive impairments and THX-150 for the treatment of infectious diseases. Recently, Canadian marijuana producer FSD Pharma (OTC:FSDDF) announced that it would acquire Therapix Biosciences for $48 million in stock.
Tilray Inc (NASDAQ:TLRY)
In July 2018, Tilray became the first pure-play cannabis company to list on NASDAQ, and its stock quickly captured attention as it surged eightfold in just two months after the IPO.
The company was founded in 2013, and in 2016 it became the first medical marijuana producer in North America to receive a good manufacturing practices certification. Tilray’s production capacity currently lags behind giants like Aurora or Canopy Growth at around 15,000 kilograms. It has been investing in expansion and aims to have over 900,000 square feet of production capacity by the end of the year.
22nd Century Group, Inc. (NYSE: XXII)
This plant biotechnology company is mostly known for its workings in the tobacco industry, more precisely for its efforts to make smoking less unhealthy by minimizing the levels of nicotine in the tobacco plant. The company developed its own proprietary, reduced-nicotine tobacco varieties ending up with a tobacco product that looks, smokes and tastes like a usual cigarette but contains 95% less nicotine.
22nd Century Group entered the cannabis space for the first time back in 2014 via a research collaboration with Anandia Labs, obtaining in that manner the U.S. right from Anandia to core patents covering the cannabinoid biosynthetic pathway in hemp/cannabis plants. Furthermore, the company got access to many new hemp-cannabis plant lines such as those with no THC, and those with higher levels of CBD or CBG, which are still part of its plant development pipeline. 22nd Century Group works on developing new hemp/cannabis plants with optimized and unique cannabinoid profiles and advantageous agronomic features.
The company said its most valuable current partnership covering the hemp/cannabis industry is with KeyGene, an AgBiotech company with a specialty in crop enhancement by molecular breeding.
Village Farms International, Inc. (NASDAQ:VFF)
Village Farms International is a vertically integrated greenhouse grower and the only publicly traded greenhouse business in Canada. It manufactures and sells fresh produce from its large greenhouses located in Texas and British Columbia and its partner greenhouses in British Columbia, Mexico, and Ontario. The company is connected to the cannabis industry via its majority ownership position in Pure Sunfarms, a Canada-based cannabis growing operations. Furthermore, the company has plans to establish itself as a vertically integrated leader in the U.S hemp-derived CBD market, already having two joint ventures – Village Fields Hemp USA, LLC and Arkansas Valley Green and Gold Hemp LLC.
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)
Zynerba Pharmaceuticals is focused on developing transdermal cannabinoid therapies for rare and near-rare neuropsychiatric diseases. Among its product candidates is ZYN002 CBD for children and adolescents with Fragile X syndrome, a genetic condition that causes intellectual disability, behavioral and learning challenges and is the most commonly known single-gene cause of autism spectrum disorder. Other targeted conditions include developmental and epileptic encephalopathies and adult epilepsy.
Non-Cannabis Companies With Interests In The Space
AbbVie, Inc. (NYSE:ABBV)
This biopharmaceutical company works on creating solutions to help treat various health conditions, from those life-threatening diseases to other chronic disorders. Its core focus is on four therapeutic fields – oncology, neurosciences, virology, and immunology. Its main connection to the cannabis industry lies in its drug, called Marinol, or Dronabinol, which is created of a synthetic form of marijuana. Marinol is used to help with nausea and vomiting caused by chemotherapy, and also to treat the loss of appetite in patients suffering from AIDS.
Altria Group, Inc. (NYSE:MO)
Altria Group is known as one of the biggest manufacturers and advertisers of tobacco, cigarettes and similar products in the world. While it runs its operations across the world, its main headquarters are located in Virgina, outside of the city of Richmond. Its connection to the cannabis sector is through its considerable stake in a Canada-based pure-play cannabis stock Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON).
Scotts Miracle-Gro Company (NYSE:SMG)
This is a company that produces and sells consumer lawn, garden and pest control products, but some websites consider it a cannabis stock, only because its products can be used in the cannabis industry. In its 2019 Annual Report, the company also states under the ‘risks’ section that end user may buy their products to cultivate cannabis. “Our gardening products, including our hydroponic gardening products, are multi-purpose products designed and intended for growing a wide range of plants and are generally purchased from retailers by end-users who may grow any variety of plants, including cannabis.”
Psychemedics Corporation (NASDAQ:PMD)
This is a provider of hair testing services for the detection of drugs of abuse, offering marijuana hair drug tests as well.
This article was last updated in April of 2020.
Copyright © 2021 Benzinga (BZ Newswire, http://www.benzinga.com/licensing). Benzinga does not provide investmentadvice. All rights reserved. Write to editorial@benzinga.com with any questions about th
INCC NEWS...
SARASOTA, FL / ACCESSWIRE / May 11, 2021 / INCC ( International Consolidated Companies, Inc. (OTC PINK:INCC)) Shareholder Update:
ON April 2021 :
INCC became OTC markets compliant.
INCC returned 394mm shares to treasury.
INCC reduced its Authorized Shares, by 1.9B, from 8.9B to 7B.
INCC added Thomas J. Megale , CPA to its Board of directors.
INCC issued 220,678,371 shares to TJ Megale and CJ Ornburg each respectively for their service on the Board of Directors. As of these two issuances there are now 7B shares issued and outstanding of INCC common stock. The Authorized has been capped at 7B.
April 30 th INCC executed a definitive agreement to acquire Blue Plant Farms, LLC . Blue Plant Farms produces CBD hemp oil products under several brand names offering improved bioavailability through the Company's proprietary water-soluble formulations.
Blue Plant Farms' product suite includes:
EEZ-AWAY™ OTC Drug Single Application CBD with Emu Oil for topical pain relief
CBD Millennial Blend™ Coffees w/25gm Full Spectrum Hemp Oil in K-Cup capsules
NOOTROPIC™ Blueberry Hemp-Shroom Nootropic Shot for well-being.
BLUDOG™ Phyto-Cannabinoid for Dogs & Cats with 250 mg CBD
EEZ-AWAY™ is the first BPF product to use PureForm CBDTM. 100% Nature-Identical CBD. The exact same molecule, every time. No THC or any other hallucinogens are ever present in starting materials or finished product.
Since PureForm CBDTM is manufactured in their labs, where there are no production capacity constraints due to crop damage or limitations of any kind; No hemp or cannabis-based regulatory constraints; No: Toxic Impurities, Heavy Metals, Pesticides, Neurotoxins, or Mycotoxins. No Variability in Product Quality.
CBD is cannabidiol, one of 140 cannabinoids -naturally occurring compounds found in cannabis plants. CBD is cannabidiol, one of 140 cannabinoids -naturally occurring compounds found in cannabis plants. Generally speaking, Research supports CBD's benefits in a range of conditions.
Terms of the Deal: $5MM in Preferred Z shares (4mm A. Uccello / 1MM C.J. Ornburg); Preferred Z shares are not convertible to the Company's common shares.
Sales Milestones and Bonus Structure
Sales Bonus Shares
Year 1= $5,266,499 1mm Preferred Z shares
Year 2= $20,180,835 2mm. Preferred Z shares
Year 3= $ 36,800,835 3mm Preferred Z shares
Year 4= $ 53,420,835 4mm Preferred Z shares
INCC anticipates launching the Company's National Go-To-Market strategy on July 1, 2021 through Blue Plant Farms' sales and distribution contract with a 90,000-member convenience store association, with initial goals calling for insertion of products into 5,000 convenience stores over the next 24 months.
Valuation Econometrics was engaged by INCC to value BPF on the merits of its contract for implementation of 5,000 C-stores and only the (1) EEZ-AWAY™ product. This valuation does not include any other products or distribution channels including additional C-stores.
In addition, INCC today announced the addition of Thomas J. Megale , CPA to the Company's board of directors, joining Antonio Uccello - CEO and Chairman of the Board, and Jeffrey Ornburg - Director.
Antonio Uccello - Chief Executive Officer / Chairman of the Board
Mr. Uccello is the founder, President, Chief Executive Officer, Chairman of the Board of Directors and the Chief Financial Officer of the Company. Mr. Uccello attended college at the University of Connecticut and took graduate courses at Hunter College in New York City . Mr. Uccello has been in the securities industry for 13 years. Mr. Uccello has extensive experience in finance and is responsible for the over-all profitability of the Company.
C. Jeffrey Ornburg - Director
Jeffrey Ornburg was the co-founder and Managing Partner of Excelsior Benefits, Excelsior Companies, and Excelsior Endeavors. Excelsior Benefits is a national general agency operating in the small to mid-market employee benefits. Representing United Healthcare , Blue Cross Blue Shield , Principal Financial, TransAmerica, Human. Mr. Ornburg played an integral role in growing the agency to over a $1.8 billion in annualized premium before recently being acquired by United Healthcare . Excelsior Companies is a national general agency for LifeLock 's employee benefits division and has recently been acquired by Symantec. Prior to starting Excelsior Jeff was a Sr. Vice President with the Principal Financial Group and has sat on the boards at UHC, BCBS and TransAmerica and was the board chair for Lake Tahoe School . Jeff earned a BSBA in Aerospace Science from the University of North Dakota and currently resides in Incline Village, NV.
Thomas Megale - Director
Thomas Megale is on the board of Greenrose Acquisition Corp. and Managing Member at T J Megale CPA PLLC . He previously was Partner at Abbate & Megale. Mr. Megale received undergraduate degree from Boston College School of Management 1981.
About International Consolidated Companies, Inc.
International Consolidated Companies (INCC) was founded in 2002. INCC is focused on acquiring and growing businesses that offer innovation, quality, and cost-efficient Cannabis technologies.
Forward-looking disclaimer
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risk and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from the statements made herein.
More Information: Antonio Uccello , INCC (949-315-0244) (baltic38dp@me.com),
@baltic38dp
http://www.BluePlantFarms.com
SOURCE: International Consolidated Companies, Inc.
View source version on accesswire.com: https://www.accesswire.com/646226/INCC-May-11-2021-Shareholder-Update
NEW JERSY Governer...
New Jersey’s broken & indefensible marijuana laws are no more.
Today, I signed historic legislation to:
?Legalize adult-use cannabis
?Decriminalize marijuana possession in small amounts
?Limit the use of previous marijuana convictions
?Create a regulated cannabis marketplace
New Jersey’s broken & indefensible marijuana laws are no more.
— Governor Phil Murphy (@GovMurphy) February 22, 2021
Today, I signed historic legislation to:
✅Legalize adult-use cannabis
✅Decriminalize marijuana possession in small amounts
✅Limit the use of previous marijuana convictions
✅Create a regulated cannabis marketplace pic.twitter.com/Y2pCKSgcn5
QBAN,,, gonnna be one of the best shares lock play.. see you @0.007
CBDL, is trying its best to pass 0.025.. lets see if today is the day for that ..
Finally , TDA adjusted my position , with the new ticker GBOX, post RS, and I am lovin it..
Take care guys...
mine , just show numbers .. with my shares size still there like a ghost town, no bid, no ask
GreenBox Raises $43.6M At Premium, Preps For Nasdaq Listing Amidst Bitcoin Boom
7:55 am ET February 17, 2021 (Benzinga)
THis one bro, kept hitting high of 0.019.. next..0.02, then 0.03,,
Can't wait for 0.1
CBDL
So it is official.. JAMN will touch 0.01.. let's do it
A new thing in the OTC penny land, old sleeping tickers are rising up from their slumber.. crazy phenomena..
Just play the move, and get out with gain if you've been bag holding for years
really,, I bought mine via TDA.. last year..Is it a new thing.
ITCJ
OMG,, 1.2B traded above 0.012,, now that is what I call heavy loading..
wow, I may as well up my prediction from 0.03 to 0.3 .LOOOOOL
Lets gooo CBDL , only 19min of trading time left
XALL and SGMD are doing me fine today
where is a wall-smasher when u need one....
SGMD
There it is, ask block @0.0067...
SGMD
... SGMD trading thinly,,, 0.01 is coming... watch L2, they gonna fake ask jamm it, they looking for shares..
CBDL.. common push harder.. lets go ..0.02
nah, level 2 ask is so thin.. 0.03 first round.. next , I am not sure
CBDL
Who can buy OTC stocks premarket.. none of my broker allowing that..
Anyway.. CBDL trading PRE-MARKET @0.012.. That is how high it touched back in 12/2020.. so a full circle..
I Think CBDL will open with huge gap up,, and may touch 0.02.. and guess who are gonna show up,,, all the negative nay sayers..LOOOL
CBDL
......CBDL NEWS
CBD Life Sciences Inc. (CBDL) in Final Stages with AMAZON
7:01 am ET February 10, 2021 (Accesswire) Print
SCOTTSDALE, AZ / ACCESSWIRE / February 10, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announces the company is in Final Stages with Amazon.
CBD Life Sciences Inc. is proud to announce that the company is in the Final Stages with getting its Hemp products on Amazon. The company decided to introduce the addition of its Hemp products on the shopping giant, Amazon.com, in a move that emphasizes the importance of hemp in the future of both LBC Bioscience Inc. and the nutritional hemp market which is "blowing up" around the world. The products we plan to distribute on Amazon focus more on the Health & Wellness side of things which would be our top selling Pain Relief Cream along with Anxiety and Sleep Tinctures.
Amazon is going to be greatly beneficial to CBD Life Sciences Inc and this is why: There are many Hemp Companies on Amazon but, President & CEO Lisa Nelson states "All of our products are Organic & Kosher, and that is one leverage we have over the competition. With that being said, we expect to gain explosive revenue in the upcoming months, and we couldn't be more excited to get the ball rolling!"
In 2021, Amazon is one of the top ways to grow your business and get your products in front of more people.
CBD Life Sciences Inc. has already identified several potential cultivation sites and is aggressively pursuing amazing new opportunities in Arizona's new recreational cannabis market. This new law gives CBD Life Sciences Inc. the capability to offer licensed retailers CBD Life Sciences Inc. premium cannabis products, which are then made available for sale to thousands of future recreational cannabis customers in addition to current cannabis sales to existing medical-use dispensaries in Arizona.
Image: https://www.accesswire.com/users/newswire/images/628855/Picture13.png
Video 1: https://streamable.com/5md9ym
Video 2: https://streamable.com/yb7pyd
The number of benefits CBD has is tremendous! These benefits include help with behavioral and neurological complications such as ADD/ADHD, anxiety, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD can also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its 100mg CBD Bath Bombs, CBD Flower, CBD Hemp Smokes, 1500 MG Premium Berry Drops, 100MG CBD Tablets and our tasty CBD Gumballs. Or, shop our top-selling products (based on order frequency), which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
Why Shop LBC Bioscience?
Large Selection of Products (over 50 items and growing)100% USA Made Products "organic & kosher."30% off on all products using code "LBC30"
LBC Bioscience Inc. accepts Visa, MasterCard, American Express, Discover, etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.
Ten Associates LLC
Contact: Thomas E. Nelson
Telephone: (480) 326-8577
Email: tenassociates33@gmail.com
Website: www.tenassociatesllc.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking
SOURCE: CBD Life Sciences Inc.
View source version on accesswire.com:
https://www.accesswire.com/628855/CBD-Life-Sciences-Inc-CBDL-in-Final-Stages-with-Amazon
.... CBDL NEWS
CBD Life Sciences Inc. (CBDL) in Final Stages with Amazon
7:01 am ET February 10, 2021 (Accesswire) Print
SCOTTSDALE, AZ / ACCESSWIRE / February 10, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. President & CEO, Lisa Nelson announces the company is in Final Stages with Amazon.
CBD Life Sciences Inc. is proud to announce that the company is in the Final Stages with getting its Hemp products on Amazon. The company decided to introduce the addition of its Hemp products on the shopping giant, Amazon.com, in a move that emphasizes the importance of hemp in the future of both LBC Bioscience Inc. and the nutritional hemp market which is "blowing up" around the world. The products we plan to distribute on Amazon focus more on the Health & Wellness side of things which would be our top selling Pain Relief Cream along with Anxiety and Sleep Tinctures.
Amazon is going to be greatly beneficial to CBD Life Sciences Inc and this is why: There are many Hemp Companies on Amazon but, President & CEO Lisa Nelson states "All of our products are Organic & Kosher, and that is one leverage we have over the competition. With that being said, we expect to gain explosive revenue in the upcoming months, and we couldn't be more excited to get the ball rolling!"
In 2021, Amazon is one of the top ways to grow your business and get your products in front of more people.
CBD Life Sciences Inc. has already identified several potential cultivation sites and is aggressively pursuing amazing new opportunities in Arizona's new recreational cannabis market. This new law gives CBD Life Sciences Inc. the capability to offer licensed retailers CBD Life Sciences Inc. premium cannabis products, which are then made available for sale to thousands of future recreational cannabis customers in addition to current cannabis sales to existing medical-use dispensaries in Arizona.
Image: https://www.accesswire.com/users/newswire/images/628855/Picture13.png
Video 1: https://streamable.com/5md9ym
Video 2: https://streamable.com/yb7pyd
The number of benefits CBD has is tremendous! These benefits include help with behavioral and neurological complications such as ADD/ADHD, anxiety, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD can also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.
LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its 100mg CBD Bath Bombs, CBD Flower, CBD Hemp Smokes, 1500 MG Premium Berry Drops, 100MG CBD Tablets and our tasty CBD Gumballs. Or, shop our top-selling products (based on order frequency), which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.
Why Shop LBC Bioscience?
Large Selection of Products (over 50 items and growing)100% USA Made Products "organic & kosher."30% off on all products using code "LBC30"
LBC Bioscience Inc. accepts Visa, MasterCard, American Express, Discover, etc.
Shareholders and interest holders may also stay current with LBC Bioscience Inc Updates:
LBC Bioscience Inc's Main Website at www.lbcbioscienceinc.com
Twitter: https://www.twitter.com/lbcbioscience
Facebook: https://www.facebook.com/lbcbioscience
Instagram: https://www.instagram.com/lbcbioscience
About LBC Bioscience Inc.
LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Gumballs, Honey Sticks, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets and more. LBC's products can be viewed and purchased on the Company's website at www.lbcbioscienceinc.com.
Ten Associates LLC
Contact: Thomas E. Nelson
Telephone: (480) 326-8577
Email: tenassociates33@gmail.com
Website: www.tenassociatesllc.com
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking
SOURCE: CBD Life Sciences Inc.
View source version on accesswire.com:
https://www.accesswire.com/628855/CBD-Life-Sciences-Inc-CBDL-in-Final-Stages-with-Amazon
ITCJ... Behaving like a share locked Play.. thin ask size and moving fast up..
nice...
CBDL, See you @0.02... GLTYA GUYS
Bid size , rising,, 10mil @0.006
CBDL
Ask is very thin.. watch L2.. this is gonna gap
CBDL
...LGBS.. Never knew will touch this high.. I was a bag holder since 2019.. Now I AM NOT...
LOVE this MARKET
<< Link Back